Opinion: Cokie Roberts: A beacon for cancer survivors like me
Cokie Roberts wore about as many hats as her full name, Mary Martha Corinne Morrison…
Author: STAT
STAT Plus: To speed drug development, Mass. General to begin ALS trials that test several compounds at once
Massachusetts General Hospital will soon start the first clinical trial that simultaneously tests multiple potential…
STAT Plus: Under a formal new FDA proposal, e-cigarette makers will have to share marketing plans and safety studies
WASHINGTON — Amid a youth vaping epidemic and a spate of mysterious vaping-related illnesses, the…
STAT Plus: Sun Pharma shipped medicines into Alabama for two years without a permit
The Alabama Board of Pharmacy is weighing whether to renew a permit for Sun Pharmaceuticals…
STAT Plus: Generic makers claim Medicare Part D plans crowd them out, hurting seniors
Amid ongoing rancor over the cost of prescription medicines, the trade group representing generic drug…
To sleep, perchance to forget? Scientists pinpoint in mice the neurons that control memory while dreaming
A version of this Q&A first appeared in STAT’s Morning Rounds. You can subscribe to…
Opinion: Health care providers: canaries in the coal mines of American society?
For hundreds of years, health care providers have been on the front lines of social…
STAT Plus: Pharmalittle: Pelosi unveils aggressive drug pricing plan; Novartis says baby death not related to gene therapy
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Pelosi’s drug pricing plan would let Medicare negotiate prices for up to 250 drugs
WASHINGTON — House Speaker Nancy Pelosi is unveiling her long-awaited plan to lower drug prices…
STAT Plus: Ginkgo Bioworks scores an eye-popping valuation with latest fundraise
Quick: What’s the most valuable venture-backed startup in Boston? Hint: If you don’t follow biotech…
STAT Plus: A biotech startup hopes to disarm cancer by targeting a genetic bandolier
Cancer, with all its wiles, has figured out how to withstand science’s best efforts by…
Opinion: Eliminating ‘tensions’ in health care: a litmus test for innovation
The term “innovation,” once considered an insult in religious sectors, has garnered a cult following…
Democrats still have questions about Nancy Pelosi’s drug pricing plan
WASHINGTON — For months, Nancy Pelosi has kept even her fellow Democrats in the dark…
STAT Plus: Flawed trials supported half of recent approvals of cancer drugs in Europe, study says
As drug makers race to bring cancer treatments to market, a new study finds about…
Opinion: Constant, rapid testing is key to creating the ‘learning health system’ of the future
In this era of evidence-based medicine, you’d be right to expect hospitals and doctor’s offices…
STAT Plus: Pharmalittle: Senators ask FTC to probe pharma mergers; is the Purdue settlement blood money?
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Opinion: Why didn’t nonprofits and the NIH require ‘reasonable’ pricing for Zolgensma? That may happen in France
When a new drug emerges from research largely funded by grants from charities and government…
STAT Plus: Martin Shkreli’s drug company is losing money — and its salesforce feels cheated
Phoenixus AG, the drug company founded and controlled by Martin Shkreli, has maintained a low…
‘Please know you’re not alone’: For dementia caregivers, a place to share with strangers — and be honest
Barbara Metcalf and Mary Smallwood live 826 miles apart. They’ve never met in person. If…
STAT Plus: Lawmakers ask FTC to scrutinize pharma mergers over antitrust concerns
Worried about a lack of competition and rising drug prices, several U.S. senators have asked…
STAT Plus: Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes
As controversy continues over prescription drug pricing, a new study finds that Medicare Part D…
STAT Plus: FDA and counterparts in Canada, Australia to collaborate on cancer therapy reviews
In an effort to speed the process of getting drugs to patients around the world,…
TV personality Dr. Oz is now on the board of a biotech company
One biotech company’s newest director has a very familiar face. Dr. Mehmet Oz will be…
Opinion: Tech companies use of artificial intelligence to mine hidden health data is dangerous
Imagine sending a text message to a friend. As your fingers tap the keypad, words…
STAT Plus: Reeve Foundation to invest in paralysis-treatment companies, as more nonprofits act like VCs
Nonprofits seeking to advance medical research have long operated from a standard playbook, soliciting grant…
With ominous TV spots and a senior ‘strike force,’ AARP launches an all-out attack on pharma
As beachgoers soaked up the sun on a balmy August day in Ocean City, Md.,…
Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say
WASHINGTON — Federal prosecutors have charged a San Diego couple with stealing trade secrets from…
STAT Plus: Former CVS head’s gift will bolster neuroscience research at University of Rhode Island
KINGSTON, R.I. — Former CVS chief executive Thomas M. Ryan and his wife are giving…
Opinion: A dangerous view: Why it’s a mistake for medical schools to ignore social justice
During my first days as a supervising resident physician at a large urban hospital, two…
STAT Plus: Wholesale drug prices have been falling, and so have net prices
Amid continuing political pressure on drug makers, a new analysis finds that brand-name companies increased…
FDA and EMA are now probing carcinogen in Zantac and other heartburn meds
Regulators in the U.S. and Europe are investigating why traces of a possible carcinogen were…
Opinion: Wider use of assisted outpatient treatment could help individuals with mental illness
In the wake of back-to-back mass shootings in El Paso, Texas, and Dayton, Ohio, President…
Opinion: 5 things hospitals can do today to keep women from dying during childbirth
It is safer to fly by plane anywhere in the world than it is to…
STAT Plus: A consultant is suing Nocion Therapeutics for allegedly promising him the CEO job — and then passing him over
A Connecticut pharma consultant claims he was offered the CEO job at a well-connected biotech…
‘The switch’ was supposed to be a major step toward eradicating polio. Now it’s a quandary
Three years ago, the leaders of the international campaign to eradicate polio pulled off a…
STAT Plus: Right to try ‘remains a bust,’ as many drug makers prefer FDA reviews
Despite the hubbub over the “right-to-try” law, a recent survey found that nearly half of…
Listen: Pelosi’s drug pricing plan, Moderna’s mRNA drug factories, and a DIY disease cure
House Speaker Nancy Pelosi’s drug pricing plan is aggressive, but is it viable? Can Moderna…
Historians push to create public archive of documents from massive opioid litigation
In settling lawsuits against them, companies often insist that all of the documents and depositions…
Opinion: Cancer researchers’ failure to disclose industry payments damages patient trust — and care
Treating cancer is one of the most difficult medical challenges of our time. In addition…
Opinion: Don’t let the opioid settlement fritter away funds like the tobacco settlement did
In response to the opioid epidemic in the U.S., cities, counties, states, insurers, and medical…
It’s not just bosses who harass health workers: Hospitals start addressing patients’ ‘egregious’ behavior
At Mayo Clinic last year, a male patient groped a female doctor in the presence…
After nearly dying five times, a young doctor learned to treat himself. Now he wants to help others with rare disease
Dr. David Fajgenbaum has nearly died not once, but five times. The cause each time…
In a CRISPR first, therapy intended to cure HIV patient appears safe — though ineffective
An HIV-positive man in China is doing well after receiving infusions of donor cells whose…
STAT Plus: FDA rebukes Sprout over a statement claiming warning on its female libido pill was removed
At the insistence of regulators, Sprout Pharmaceuticals has recanted statements made in a press release…
OxyContin maker Purdue Pharma agrees to tentative settlement in opioid lawsuits
HARTFORD, Conn. — OxyContin maker Purdue Pharma reached a tentative deal Wednesday with about half…
Opinion: New public charge rule amounts to child abuse
If one of our patients withheld food or medication from her child, we would report…
New evidence shows why the HPV vaccine is as important for boys as girls
Earlier this year, the biotech community mourned the loss of Michael Becker, a former pharmaceutical…
‘There’s no such thing as anonymity’: With consumer DNA tests, sperm banks reconsider long-held promises to donors
For generations, it was a basic tenet of donating sperm: Clinics could forever protect their…
STAT Plus: BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’
WASHINGTON — The sprawling trade association for companies making everything from weed killer to CAR-T…
STAT Plus: National Institute on Aging awards one of the largest federal grants ever for dementia care
The National Institute on Aging has awarded a five-year grant worth up to $53.4 million…